The marketing approach to determining the main indicators of economic efficiency of a hepatotropic drug
Journal Title: Соціальна фармація в охороні здоров’я - Year 2018, Vol 4, Issue 3
Abstract
Aim. To substantiate the expediency of development of an arginine-based hepatotropic drug using prognostic determination of the main indicators of economic efficiency. Materials and methods. The legislative and regulatory base, data of the Morion information and retrieval system for 2013-2017, special literature and the results of the authors’ previous studies were used. The cost and rentability (R) of the drug manufacture, the amount of cash flows in three main variants of the project development, the discounted pay-back period (DPB) and the return on investment (ROI) were calculated. The historical, logical, marketing, and mathematical-statistical methods of research were used. Results. Development of new drugs requires large amounts of money (from tens or hundreds of millions to 1-3 billion USD) for a significant period of time (from 3-4 to 10-14 years). The availability of the population to a drug increases in conditions of its sufficient production and prices acceptable to consumers. This is ensured by the presence of several manufacturers of a similar drug at the market. Arginine-based drugs have been found to have a wide range of pharmacological effects, forming a large potential volume of the market segment of the drug. The basic indicators of the economic efficiency of development of the arginine-based drug and marketing indicators of the market characteristics of the drug have been determined. Cash flows of income have been analyzed; and the terms of the return of discounted investments into the project in three variants of development of market events have been determined. The results of calculations on the basis of the marketing approach to the comprehensive market analysis of the characteristics of the arginine-based drug have confirmed the economic efficiency and investment attractiveness of the project. Conclusions. The research on determining of the main indicators of the project economic efficiency has shown the feasibility of developing and introducing the arginine-based drug into the production assortment, as well as investment attractiveness of the project.
Authors and Affiliations
V. V. Malyi, Moussa Istanis Marvek Medhat
Keywords
Related Articles
- EP ID EP671024
- DOI 10.24959/sphhcj.18.123
- Views 158
- Downloads 0
Визначення мотиваційних профілів спеціалістів фармації в аптечних закладах
Виявлення джерел мотивації, а не конкретної потреби чи фактора мотивації спеціалістів фармації (СФ) дозволить керівництву аптечного закладу (АЗ) в залежності від наявних коштів, часу, організаційної культури, стадії розв...
Поводження з фармацевтичними відходами як важлива складова ефективної реалізації соціальної функції аптек за умов упровадження належної аптечної практики
Мета: формулювання терміна «фармацевтичні відходи» як важливої понятійної категорії, що відображає розширення спектра соціальної функції аптек, розробка сучасних підходів щодо упровадження принципів «зеленої фармації» в...
Научно-теоретическое обоснование направлений развития маркетинговой коммуникативной деятельности субъектов фармацевтического рынка в контексте концепции социально-этического продвижения
Цель: научно-теоретическое обоснование и совершенствование прикладных положений и рекомендаций по направлениям развития маркетинговой коммуникативной деятельности субъектов фармацевтического рынка в контексте концепции с...
The study of the basic factors of unfair advertising of medicines in Ukraine and development of proposals for their prevention
Aim. To study the factors causing unfair advertising of medicines in Ukraine and development of proposals for their prevention. To achieve this aim the following tasks have been solved: the analysis of the main tendenci...
The analysis of modern organizational and economic approaches to functioning of pharmacies in the Republic of Poland
Aim. To analyze modern organizational and economic approaches to functioning of pharmacies in Poland. Materials and methods. The data from the legislative and regulatory framework governing the pharmaceutical activity in...